As Senior Vice President, India Operations at REV Clinical, Dr. Sandeep Singh leads global clinical programs, focusing on operational excellence, regulatory compliance, and strategic execution across therapeutic areas. With well over two decades of clinical research experience, Dr. Singh began his career as a medical practitioner before transitioning to the pharmaceutical industry in 2005. He has held leadership roles at IQVIA, Alkem Laboratories, Unichem Laboratories, and Veeda Clinical Research, where he built biopharmaceutics teams, managed BE and Phase I trials, and interfaced with global regulators including US FDA, EMA, ANVISA, and TGA. Dr. Singh is a medical graduate with a postgraduate diploma in clinical research and has extensive expertise in biopharmaceutics, adaptive trial design, and regulatory strategy.